On January 6, 2022, Gilead Sciences, Inc. announced that Brett A. Pletcher plans to retire from his position as the company's executive vice president, corporate affairs, general counsel and corporate secretary. No formal date has been established for Mr. Pletcher's retirement, and Mr. Pletcher expects to continue in his role while the company works to identify a successor and thereafter to assist in the transition, which is expected to occur by the end of summer 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.08 USD | +0.07% | +0.22% | -17.20% |
Apr. 24 | HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69 | MT |
Apr. 23 | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.20% | 83.65B | |
+25.61% | 660B | |
+23.16% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.60% | 219B | |
-9.73% | 196B | |
+6.69% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences, Inc. Announces Retirement of Brett A. Pletcher as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary